?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
496 Unternehmen gefunden • Seite 9 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sichuan Kelun Pharmaceutical Co Ltd | 47.6 | Arzneimittel (Pharmazeutisch) | China | 9.7 Mrd. USD | 32.84 | - | 3.52 | 2.49 | ▲ 2.37% | ▲ 15.46% | 1.49% | - | - | 9.19% | ▲ 1.01% | 13.44% | ▲ 2.04% | 5.51% | ▼ -0.93% | 5 / 9 | 6,09 | 17-fach | 25 / 100 | −2,7 / 100 | −4,43 | |
| PharmaBlock Sciences Nanjing Inc Class A | 47.4 | Arzneimittel (Pharmazeutisch) | China | 1.5 Mrd. USD | 48.20 | - | 4.80 | 2.22 | ▲ 14.07% | ▼ -0.05% | 0.92% | - | - | 9.31% | ▼ -6.91% | 12.90% | ▼ -6.00% | 26.70% | ▲ 12.84% | 6 / 9 | 9,18 | 5-fach | 8 / 100 | −6,6 / 100 | −1,49 | |
![]() | SIGA Technologies Inc | 47.2 | Arzneimittel (Pharmazeutisch) | USA | 0.2 Mrd. USD | - | - | 4.43 | 1.44 | ▼ -5.41% | ▼ -16.19% | - | - | - | 24.63% | ▼ -4.26% | 25.05% | ▼ -7.13% | 45.58% | ▲ 7.16% | 6 / 9 | 16,23 | unbegrenzt | 30 / 100 | −9,2 / 100 | −4,02 |
![]() | CSPC Pharmaceutical Group Ltd | 46.7 | Arzneimittel (Pharmazeutisch) | China | 11.7 Mrd. USD | 9.40 | 6.38 | 2.08 | 2.07 | ▲ 1.44% | ▼ -5.53% | 4.14% | - | - | 15.32% | ▼ -1.50% | 15.27% | ▼ -1.78% | 15.74% | ▼ -0.01% | 4 / 9 | 7,07 | > 50-fach | 37 / 100 | −4,4 / 100 | −2,52 |
![]() | Biogen Inc | 46.5 | Arzneimittel (Biotechnologie) | USA | 36.1 Mrd. USD | 103.62 | 17.41 | 3.50 | 1.91 | ▼ -6.11% | ▼ -20.22% | - | - | - | 13.18% | ▼ -1.51% | 19.14% | ▼ -1.52% | 20.90% | ▼ -0.44% | 5 / 9 | 5,62 | 7-fach | 23 / 100 | −3,1 / 100 | −2,49 |
| Humanwell Healthcare Group Co Ltd | 46.5 | Arzneimittel (Pharmazeutisch) | China | 4.8 Mrd. USD | 15.58 | 147.07 | 1.32 | 1.64 | ▲ 2.99% | ▲ 13.03% | 2.45% | - | 3 Jahre | 7.74% | ▼ -0.39% | 15.96% | ▲ 0.42% | 7.45% | ▲ 1.78% | 7 / 9 | 4,86 | 9-fach | 34 / 100 | −2,0 / 100 | −2,84 | |
| GuangYuYuan Chinese Herbal Medicine Co Ltd | 46.2 | Arzneimittel (Pharmazeutisch) | China | 0.9 Mrd. USD | 95.61 | - | 4.61 | 3.64 | ▲ 4.30% | ▲ 14.52% | - | - | - | 4.60% | ▲ 11.15% | 10.14% | ▲ 13.87% | 14.00% | - | 6 / 9 | 4,14 | 28-fach | 38 / 100 | −5,6 / 100 | −3,87 | |
| China Resources Pharmaceutical Group Ltd | 46.1 | Arzneimittel (Pharmazeutisch) | Hong Kong | 3.6 Mrd. USD | 5.10 | 1.33 | 0.08 | 0.39 | ▲ 12.21% | ▲ 6.43% | 5.33% | - | - | 1.50% | ▼ -0.15% | 4.63% | ▲ 0.18% | 6.28% | ▲ 0.83% | 9 / 9 | 3,03 | 6-fach | 20 / 100 | −7,5 / 100 | −1,89 | |
| Alphamab Oncology | 45.4 | Arzneimittel (Biotechnologie) | China | 0.8 Mrd. USD | - | - | 10.47 | 3.22 | ▲ 156.25% | ▼ -33.17% | - | - | - | -20.12% | ▲ 74.58% | -27.07% | ▲ 76.76% | -27.83% | ▲ 88.75% | 2 / 9 | 4,87 | −4,3-fach | 20 / 100 | 0,5 / 100 | −0,77 | |
| Abbisko Cayman Ltd | 45.4 | Arzneimittel (Biotechnologie) | China | 0.6 Mrd. USD | - | - | 39.64 | 1.77 | - | - | - | - | - | 9.27% | ▲ 1495.07% | 4.56% | ▲ 844.34% | 12.37% | ▲ 531.92% | 7 / 9 | 4,47 | −33,2-fach | 25 / 100 | −1,0 / 100 | - | |
![]() | Genomma Lab Internacional S.A.B. de C.V | 45.3 | Arzneimittel (Pharmazeutisch) | Mexiko | 0.8 Mrd. USD | 8.32 | 8.74 | 0.83 | 1.16 | ▲ 4.81% | ▲ 1.88% | 5.53% | - | 2 Jahre | 9.20% | ▲ 0.13% | 21.41% | ▲ 0.59% | 11.56% | ▲ 1.52% | 4 / 9 | 5,04 | 4-fach | 46 / 100 | −1,8 / 100 | −2,60 |
| Shanghai Yizhong Pharmaceutical Co Ltd | 44.8 | Arzneimittel (Pharmazeutisch) | China | 1.1 Mrd. USD | 105.61 | - | 22.37 | 4.99 | - | - | - | - | - | 20.23% | ▲ 18.00% | 19.58% | ▲ 43.57% | -47.14% | ▲ 239.76% | 6 / 9 | 18,68 | > 50-fach | 21 / 100 | 5,5 / 100 | −1,64 | |
![]() | Swedish Orphan Biovitrum AB (publ) | 44.3 | Arzneimittel (Pharmazeutisch) | Schweden | 17.3 Mrd. USD | 25.63 | 25.99 | 5.31 | 3.74 | ▲ 13.10% | ▼ -31.82% | - | - | - | 1.69% | ▼ -3.02% | 28.50% | ▲ 1.02% | 30.19% | ▼ -0.50% | 5 / 9 | 2,35 | 3-fach | 18 / 100 | −12,0 / 100 | −2,60 |
| Zhejiang Hisun Pharmaceutical Co Ltd | 44.0 | Arzneimittel (Pharmazeutisch) | China | 2.2 Mrd. USD | 12.04 | - | 1.61 | 1.55 | ▼ -1.46% | ▲ 5.32% | 1.57% | ▲ 27.73% | 1 Jahre | 5.13% | ▲ 0.43% | 12.14% | ▲ 1.45% | 15.69% | ▲ 1.94% | 7 / 9 | 2,31 | 4-fach | 32 / 100 | −10,1 / 100 | −3,20 | |
| Sumitomo Dainippon Pharma Co. Ltd | 43.9 | Arzneimittel (Pharmazeutisch) | Japan | 5.5 Mrd. USD | 9.07 | 23.82 | 2.42 | 2.12 | ▼ -2.56% | ▲ 13.71% | - | ▼ -18.10% | - | 23.58% | ▲ 4.63% | 23.18% | ▲ 4.61% | - | ▼ -0.75% | 5 / 9 | 2,23 | −6,3-fach | 32 / 100 | 13,3 / 100 | −1,17 | |
| Apeloa Pharmaceutical Co Ltd | 43.6 | Arzneimittel (Pharmazeutisch) | China | 3.4 Mrd. USD | 27.88 | 5629.95 | 2.53 | 3.50 | ▲ 4.37% | ▲ 1.75% | 1.87% | - | - | 9.13% | ▼ -0.39% | 9.01% | ▼ -0.65% | 8.65% | ▲ 1.78% | 7 / 9 | 4,41 | 32-fach | 19 / 100 | −2,8 / 100 | −2,60 | |
![]() | Prestige Brand Holdings Inc | 43.6 | Arzneimittel (Pharmazeutisch) | USA | 2.3 Mrd. USD | 13.43 | 9.81 | 2.09 | 1.20 | ▲ 2.91% | ▲ 2.93% | - | - | - | 17.48% | ▲ 2.33% | 28.42% | ▲ 2.77% | 22.64% | ▲ 0.09% | 5 / 9 | 3,94 | 6-fach | 16 / 100 | −1,9 / 100 | −2,25 |
![]() | CSL Ltd | 43.2 | Arzneimittel (Biotechnologie) | Australien | 66.6 Mrd. USD | - | 23.92 | 4.23 | 4.51 | ▲ 8.73% | - | 2.06% | ▲ 7.14% | 4 Jahre | -16.43% | ▼ -7.30% | 25.55% | ▲ 1.02% | 14.22% | ▼ -2.07% | 4 / 9 | 2,84 | 3-fach | 23 / 100 | −19,0 / 100 | −3,37 |
| Celltrion Pharm Inc | 43.0 | Arzneimittel (Pharmazeutisch) | Südkorea | 1.2 Mrd. USD | 37.83 | 39.26 | 2.81 | 3.61 | ▲ 18.09% | ▲ 13.10% | 0.54% | - | - | 7.22% | ▼ -0.50% | 10.46% | ▼ -0.52% | 12.77% | ▼ -0.16% | 8 / 9 | 4,26 | 6-fach | 22 / 100 | −6,3 / 100 | −2,71 | |
![]() | Ascendis Pharma AS | 42.6 | Arzneimittel (Biotechnologie) | Dänemark | 16.4 Mrd. USD | 19.43 | 43.59 | 13.93 | 10.23 | ▲ 150.93% | ▼ -12.16% | - | - | - | -31.67% | ▲ 1083.55% | -18.92% | ▲ 1260.05% | 6.31% | ▲ 1228.74% | 5 / 9 | −7,33 | −4,6-fach | 45 / 100 | −20,8 / 100 | −2,61 |
| Dermapharm Holding SE | 42.3 | Arzneimittel (Pharmazeutisch) | Deutschland | 2.1 Mrd. USD | 13.03 | 11.14 | 1.62 | 3.56 | ▲ 7.97% | ▲ 9.06% | 2.29% | - | - | 11.37% | ▼ -2.52% | 19.03% | ▼ -3.06% | 11.97% | ▼ -2.67% | 7 / 9 | 3,05 | 4-fach | 18 / 100 | −2,2 / 100 | −1,96 | |
![]() | Takeda Pharmaceutical Co Ltd ADR | 42.3 | Arzneimittel (Pharmazeutisch) | Japan | 64.4 Mrd. USD | 26.28 | 15.23 | 2.14 | 1.37 | ▲ 8.36% | ▼ -11.57% | 3.04% | ▲ 2.72% | 3 Jahre | 4.26% | ▼ -0.99% | 11.99% | ▼ -0.65% | 13.12% | ▼ -2.00% | 8 / 9 | 1,85 | 2-fach | 16 / 100 | −5,4 / 100 | −2,28 |
| Guangdong Zhongsheng Pharmaceutical Co Ltd | 42.0 | Arzneimittel (Pharmazeutisch) | China | 3.0 Mrd. USD | 100.78 | - | 9.03 | 5.02 | ▲ 5.88% | - | 0.84% | - | - | 10.93% | ▼ -2.52% | 12.71% | ▼ -2.57% | -0.43% | ▼ -2.24% | 8 / 9 | 8,42 | 4-fach | 28 / 100 | −0,6 / 100 | −3,58 | |
| Tong Ren Tang Technologies Co Ltd | 42.0 | Arzneimittel (Pharmazeutisch) | China | 0.5 Mrd. USD | 10.55 | 2.80 | 0.56 | 0.44 | ▲ 7.07% | ▼ -3.25% | 7.11% | ▲ 1.25% | - | 6.11% | ▼ -0.91% | 12.37% | ▼ -2.19% | 22.30% | ▲ 0.05% | 5 / 9 | 9,40 | 19-fach | 23 / 100 | −10,9 / 100 | −3,20 | |
![]() | Beam Therapeutics Inc | 41.8 | Arzneimittel (Biotechnologie) | USA | 3.0 Mrd. USD | - | - | 19.05 | 2.78 | ▲ 466.27% | ▼ -16.29% | - | - | - | -57.24% | ▲ 114.93% | -274.57% | ▲ 86.62% | -257.65% | ▼ -59.65% | 5 / 9 | 6,77 | −3,2-fach | 8 / 100 | 17,9 / 100 | - |